WB
KYTX icon

WesBanco Bank’s Kyverna Therapeutics KYTX Stock Holding History

WesBanco Bank’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$983K Hold
110,300
– – 0.02% 387
2026
Q1 		$952K Buy
+110,300
New +$919K 0.03% 380

Other funds holding KYTX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
SIC
Samalin Investment Counsel Chappaqua, New York $320M AUM 20.87% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
GWM
GSB Wealth Management Guilford, Connecticut $498M AUM 27.51% 1-Year Est. Return

WesBanco Bank's KYTX Position: Q2 2026 in Review

WesBanco Bank held its Kyverna Therapeutics (KYTX) position steady in Q2 2026 at 110,300 shares worth $983K. The position accounts for 0.02% of the portfolio, ranked #387.

WesBanco Bank first reported a position in KYTX in Q1 2026 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • WesBanco Bank held 110,300 shares of Kyverna Therapeutics worth $983K as of Q2 2026.
  • WesBanco Bank left its Kyverna Therapeutics share count unchanged in Q2 2026.
  • Kyverna Therapeutics made up 0.02% of WesBanco Bank's portfolio in Q2 2026, its #387 holding.
  • WesBanco Bank first reported a position in Kyverna Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 21 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.